Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patric Teodorescu

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Frontiers in Oncology|July 23, 2020
SERS-Based Assessment of MRD in Acute Promyelocytic Leukemia?Cristina Turcas, Vlad Moisoiu, Andrei Stefancu, et al.
Frontiers in Oncology|July 23, 2020
Day 15 and Day 33 Minimal Residual Disease Assessment for Acute Lymphoblastic Leukemia Patients Treated According to the BFM ALL IC 2009 Protocol: Single-Center Experience of 133 CasesLetitia-Elena Radu, Andrei Colita, Sergiu Pasca, et al.
Journal of Clinical Medicine|October 29, 2020
B Cells versus T Cells in the Tumor Microenvironment of Malignant Lymphomas. Are the Lymphocytes Playing the Roles of Muhammad Ali versus George Foreman in Zaire 1974?Minodora Desmirean, Sebastian Rauch, Ancuta Jurj, et al.
Journal of Cellular and Molecular Medicine|June 16, 2021
Azacytidine plus olaparib for relapsed acute myeloid leukaemia, ineligible for intensive chemotherapy, diagnosed with a synchronous malignancySabina Iluta, Sergiu Pasca, Grigore Gafencu, et al.
Frontiers in Bioengineering and Biotechnology|August 9, 2021
SERS-Based Evaluation of the DNA Methylation Pattern Associated With Progression in Clonal Leukemogenesis of Down SyndromeVlad Moisoiu, Valentina Sas, Andrei Stefancu, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|January 17, 2021
Baseline characteristics of a nationwide cohort of pediatric patients with acute leukemias of Down syndromeValentina Sas, Cristina Blag, Sergiu Pasca, et al.
Frontiers in Oncology|September 26, 2019
LEAM vs. BEAM vs. CLV Conditioning Regimen for Autologous Stem Cell Transplantation in Malignant Lymphomas. Retrospective Comparison of Toxicity and Efficacy on 222 Patients in the First 100 Days After Transplant, On Behalf of the Romanian Society for Bone Marrow TransplantationAndrei Colita, Anca Colita, Horia Bumbea, et al.
Haematologica|December 15, 2022
CCRL2 affects the sensitivity of myelodysplastic syndrome and secondary acute myeloid leukemia cells to azacitidineTheodoros Karantanos, Patric Teodorescu, Marios Arvanitis, et al.
Critical Reviews in Clinical Laboratory Sciences|May 3, 2019
Transient leukemia of Down syndromeValentina Sas, Cristina Blag, Gabriela Zaharie, et al.
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|August 7, 2021
SERS-based DNA methylation profiling allows the differential diagnosis of malignant lymphadenopathyAndrei Stefancu, Vlad Moisoiu, Minodora Desmirean, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Frontiers in Oncology|July 23, 2020
SERS-Based Assessment of MRD in Acute Promyelocytic Leukemia?Cristina Turcas, Vlad Moisoiu, Andrei Stefancu, et al.
Frontiers in Oncology|July 23, 2020
Day 15 and Day 33 Minimal Residual Disease Assessment for Acute Lymphoblastic Leukemia Patients Treated According to the BFM ALL IC 2009 Protocol: Single-Center Experience of 133 CasesLetitia-Elena Radu, Andrei Colita, Sergiu Pasca, et al.
Journal of Clinical Medicine|October 29, 2020
B Cells versus T Cells in the Tumor Microenvironment of Malignant Lymphomas. Are the Lymphocytes Playing the Roles of Muhammad Ali versus George Foreman in Zaire 1974?Minodora Desmirean, Sebastian Rauch, Ancuta Jurj, et al.
Journal of Cellular and Molecular Medicine|June 16, 2021
Azacytidine plus olaparib for relapsed acute myeloid leukaemia, ineligible for intensive chemotherapy, diagnosed with a synchronous malignancySabina Iluta, Sergiu Pasca, Grigore Gafencu, et al.
Frontiers in Bioengineering and Biotechnology|August 9, 2021
SERS-Based Evaluation of the DNA Methylation Pattern Associated With Progression in Clonal Leukemogenesis of Down SyndromeVlad Moisoiu, Valentina Sas, Andrei Stefancu, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|January 17, 2021
Baseline characteristics of a nationwide cohort of pediatric patients with acute leukemias of Down syndromeValentina Sas, Cristina Blag, Sergiu Pasca, et al.
Frontiers in Oncology|September 26, 2019
LEAM vs. BEAM vs. CLV Conditioning Regimen for Autologous Stem Cell Transplantation in Malignant Lymphomas. Retrospective Comparison of Toxicity and Efficacy on 222 Patients in the First 100 Days After Transplant, On Behalf of the Romanian Society for Bone Marrow TransplantationAndrei Colita, Anca Colita, Horia Bumbea, et al.
Haematologica|December 15, 2022
CCRL2 affects the sensitivity of myelodysplastic syndrome and secondary acute myeloid leukemia cells to azacitidineTheodoros Karantanos, Patric Teodorescu, Marios Arvanitis, et al.
Critical Reviews in Clinical Laboratory Sciences|May 3, 2019
Transient leukemia of Down syndromeValentina Sas, Cristina Blag, Gabriela Zaharie, et al.
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|August 7, 2021
SERS-based DNA methylation profiling allows the differential diagnosis of malignant lymphadenopathyAndrei Stefancu, Vlad Moisoiu, Minodora Desmirean, et al.
Pageof 4